SCHEMBL17656830

SCHEMBL17656830

COCOc1cc(O)c2c(=O)c(OC)c(-c3ccc(OCCO)c(OCCO)c3)oc2c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 2/20 0.68
ABCG2 Q9UNQ0 4/20 0.65
ABCB1 P08183 3/20 0.65
ABCC1 P33527 3/20 0.65
PLG P00747 1/20 0.59
NOX4 Q9NPH5 1/20 0.59
TUBB4A P04350 2/20 0.58
TUBB P07437 2/20 0.58
TUBA3C P0DPH7 2/20 0.58
TUBA1B P68363 2/20 0.58
TUBA4A P68366 2/20 0.58
TUBB4B P68371 2/20 0.58
TUBB3 Q13509 2/20 0.58
TUBB2A Q13885 2/20 0.58
TUBB8 Q3ZCM7 2/20 0.58
TUBA3E Q6PEY2 2/20 0.58
TUBA1A Q71U36 2/20 0.58
TUBA1C Q9BQE3 2/20 0.58
TUBB6 Q9BUF5 2/20 0.58
TUBB2B Q9BVA1 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13707581 0.94 ACE2 (0.76) ACE2ABCG2ABCB1ABCC1PLG
SCHEMBL14594144 0.90 ACE2 (0.83) ACE2ABCG2ABCB1ABCC1PLG
SCHEMBL3173948 0.90 ABCG2 (0.80) ACE2ABCG2ABCB1ABCC1PLG
SCHEMBL15689700 0.89 ACE2 (0.74) ACE2ABCG2ABCB1ABCC1PLG
SCHEMBL19749974 0.88 ACE2 (0.72) ACE2ABCG2ABCB1ABCC1PLG
SCHEMBL17620268 0.86 ACE2 (0.80) ACE2ABCG2ABCB1ABCC1PLG
SCHEMBL17656837 0.86 PLG (0.79) ABCG2ABCB1ABCC1PLGNOX4
SCHEMBL3181661 0.83 CYP3A4 (0.62) ACE2ABCG2ABCB1ABCC1PLG
SCHEMBL15689632 0.83 ABCG2 (0.65) ACE2ABCG2ABCB1ABCC1PLG
SCHEMBL29738596 0.83 ABCG2 (0.65) ACE2ABCG2ABCB1ABCC1PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160096860-A1 PREPARATION METHOD OF TRIHYDROXYETHYL RUTOSIDE JINAN XINLITE TECHNOLOGY CO., LTD. (CN) 2016-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160096860-A1 PREPARATION METHOD OF TRIHYDROXYETHYL RUTOSIDE TET1, TET3, COMT ACE2 3345/4885ABCG2 1038/4885ABCB1 1492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.